By: Kairos Ventures On: April 15, 2021 In: MixComm, Portfolio News

MixComm announced it has joined the Open RF Association (OpenRF™), an open industry consortium dedicated to creating a 5G...

Read more
By: Kairos Ventures On: April 12, 2021 In: Portfolio News, Provivi

Provivi® proudly announces regulatory approval of "Pherium AL" in Indonesia. The authorization issued by the Indonesian Ministry of Agriculture...

Read more
By: Kairos Ventures On: April 9, 2021 In: Portfolio News, Stoicheia

Stoicheia, a new technology startup that uses a nanotechnology-based approach to ultrahigh throughput materials discovery, announced the first four...

Read more
By: Kairos Ventures On: April 7, 2021 In: MemVerge, Portfolio News

MemVerge™ announced the release of Memory Machine software version 1.2. The software delivers Big Memory performance and capacity leveraging...

Read more
By: Kairos Ventures On: March 30, 2021 In: Portfolio News, Vivodyne

Vivodyne, a startup developing a new bio-pharma discovery pipeline that starts and ends in lab-grown human tissues, announced today...

Read more
By: Kairos Ventures On: March 29, 2021 In: Portfolio News, Xidas

With the launch of Xidas' innovative suite of energy-harvesting solutions for IoT, the emerging tech start-up has been recognized...

Read more
By: Kairos Ventures On: March 26, 2021 In: MixComm, Portfolio News

MixComm announced that Woonsub Kim, former EVP and GM of Samsung’s Network Division, has joined its advisory board.

Read more
By: Kairos Ventures On: March 24, 2021 In: MixComm, Portfolio News

MixComm announced it is working with Dreamtech to collaborate on network infrastructure solutions, such as repeaters, customer premises equipment...

Read more
By: Kairos Ventures On: March 18, 2021 In: Amorphology, Portfolio News

Amorphology is a leader in applying advanced materials and manufacturing technologies toward improving gear production for robotics and other...

Read more
By: Kairos Ventures On: March 10, 2021 In: Linnaeus, Portfolio News

Linnaeus Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for LNS8801 for...

Read more